MediGene AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
pharmaceutical manufacturers in Europe:
sales of 38.76 million Norwegian Kroner [US$4.76 million]
(6.17 million Euro [US$6.77 million]
of which 100%
was Research & Development), and
Biotec Pharmacon ASA
based in Norway
(53.28 million Norwegian Kroner [US$6.55 million]
of which 56%
MediGene AG reported sales of 6.81 million Euro (US$7.47 million)
December of 2015.
decrease of 50.6%
versus 2014, when the company's sales were 13.78 million Euro.